What’s New For Novavax Stock?
- Tuesday, December 28, 2021, 8:14
- Market
- Add a comment
Covid-19 vaccine developer Novavax’s stock (NASDAQ: NVAX) declined by about 9% over the last week (five trading days), compared to the S&P 500 which remains up by about 1% over the same period. While there has actually been some positive news for Novavax, which indicated that its Covid-19 vaccine…
About the Author
admin123 has written 23402 stories on this site.
